Keros Therapeutics
KROS
#6458
Rank
NZ$0.98 B
Marketcap
$23.89
Share price
0.35%
Change (1 day)
-75.77%
Change (1 year)

EPS for Keros Therapeutics (KROS)

EPS in 2023 (TTM): -$7.42

According to Keros Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.60. In 2022 the company made an earnings per share (EPS) of -$6.95 a decrease over its 2021 EPS that were of -$4.22.

EPS history for Keros Therapeutics from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.426.77%
2022-$6.9564.68%
2021-$4.224.65%
2020-$4.0371.14%
2019-$2.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.65-51.98%๐Ÿ‡บ๐Ÿ‡ธ USA